National Academies Recommendations on Human Gene Editing

Click For Summary
SUMMARY

The US National Academy of Sciences and National Academy of Medicine released a comprehensive 261-page report on February 14, outlining recommendations for regulating human gene editing, particularly germline editing. The report emphasizes that germline editing should be limited to severe medical conditions with no alternative treatments and prohibits its use for human enhancement. It advocates for international cooperation, a strict regulatory framework, public involvement, and long-term monitoring of edited individuals. This report builds on a previous consensus from a 2015 summit, reinforcing the need for ethical considerations in gene editing practices.

PREREQUISITES
  • Understanding of CRISPR technology and its applications
  • Familiarity with ethical considerations in genetic research
  • Knowledge of regulatory frameworks governing biomedical research
  • Awareness of the implications of germline editing on future generations
NEXT STEPS
  • Research the ethical implications of CRISPR technology in human genetics
  • Explore international regulations on germline gene editing
  • Investigate case studies of CRISPR applications in clinical trials
  • Learn about public engagement strategies in scientific decision-making
USEFUL FOR

Researchers, bioethicists, policymakers, and anyone involved in the fields of genetics, biotechnology, and public health who seeks to understand the implications and regulations surrounding human gene editing.

Ygggdrasil
Science Advisor
Insights Author
Gold Member
Messages
3,753
Reaction score
4,198
This week on, Feb 14, the US National Academy of Sciences and National Academy of Medicine released a report giving recommendations on how https://www.physicsforums.com/insights/dont-fear-https://www.physicsforums.com/insights/dont-fear-crispr-new-gene-editing-technologies-wont-lead-designer-babies/-new-gene-editing-technologies-wont-lead-designer-babies/—making changes to the DNA of humans that are heritable across generations—should be regulated:
The 261-page document follows a 2015 National Academies summit that brought together scientists, ethicists, legal experts and patient groups from around the world. Meeting organizers wanted to survey concerns about human germline editing: genetic modifications to embryos, sperm or egg cells that can be passed on to offspring.

Given the raft of scientific, ethical and legal questions surrounding the issue, the organizers concluded at the time that scientists shouldn’t yet perform germline editing on embryos intended for establishing a pregnancy. But they decided that altering human embryos in the lab for the sake of basic research was acceptable.

The latest report builds on the earlier consensus and outlines strict limits under which scientists could proceed in the future. It recommends restricting the technique to severe medical conditions for which no other treatment exists. It also calls for international cooperation, strict regulatory and oversight framework, public input into decisions and long-term follow-ups of children who have edited genomes. The report adds that for now, genome editing should not be used for human enhancement, such as improving a person’s intelligence or giving them super-strength.
http://www.nature.com/news/us-science-advisers-outline-path-to-genetically-modified-babies-1.21474

A one-page summary of the recommended criteria for germline gene editing is available here: http://nationalacademies.org/cs/groups/genesite/documents/webpage/gene_177255.pdf

The full report can be accessed here: http://nationalacademies.org/gene-editing/consensus-study/index.htm
Popular press coverage:
Nature
New York Times
NPR
 
  • Like
Likes   Reactions: 1oldman2, Drakkith, BillTre and 2 others
Biology news on Phys.org
Lancet has a good write-up on the subject also,
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)30389-6/fulltext
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)30389-6/abstract
"With the first clinical trial using CRISPR targeting cancer cells approved in the USA in June, 2016, and the first CRISPR-edited genes injected into a patient in China in November, 2016, the race for results is under way. Although, for now, the report signals both the beginning of a new phase of productivity and an end of sorts to the debate around the way forward for human gene editing."

A very informative read, It's interesting to see the politics of business involved.
http://science.sciencemag.org/content/355/6326/680.full
http://www.nature.com/news/why-the-...chnologies-wont-lead-designer-babies/']crispr-patent-verdict-isn-t-the-end-of-the-story-1.21510[/URL]
 
  • Like
Likes   Reactions: Ygggdrasil

Similar threads

  • · Replies 8 ·
Replies
8
Views
5K
  • · Replies 2 ·
Replies
2
Views
5K
  • · Replies 1 ·
Replies
1
Views
3K
  • · Replies 2 ·
Replies
2
Views
5K
  • · Replies 2 ·
Replies
2
Views
2K
  • · Replies 1 ·
Replies
1
Views
2K
  • · Replies 11 ·
Replies
11
Views
6K
  • · Replies 13 ·
Replies
13
Views
4K
  • · Replies 2 ·
Replies
2
Views
2K